Skip to content

Liner Ablation Using Contact-force in Atrial Fibrillation

Left Atrial Liner Block Using Contact-force Catheter in Ablation for Atrial Fibrillation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03091972
Acronym
LIBCAAF
Enrollment
200
Registered
2017-03-27
Start date
2016-11-01
Completion date
2018-12-31
Last updated
2017-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent Atrial Fibrillation

Keywords

Persistent Atrial Fibrillation, Linear ablation, Catheter ablation, Contact force

Brief summary

Linear ablation is frequently used in the procedure for persistent atrial fibrillation. However, it has a limitation because of technical difficulty. Incomplete block is common and an important cause of atrial tachycardia. The association between contact force values and successful linear block has not been revealed yet. We aim to the effectiveness and safety of linear ablation by using CF sensing catheter.

Detailed description

Catheter ablation is currently accepted as a treatment option for symptomatic atrial fibrillation. Linear ablation is frequently used in the procedure for persistent atrial fibrillation. Multiple studies have shown benefit of linear ablation. However, it has a limitation because of technical difficulty. Incomplete block is common and an important cause of atrial tachycardia. Contact-force (CF) monitoring during procedure has recently been available. This technology appears to significantly decrease procedure time and short term reconnection incidence in pulmonary vein (PV) isolation. It also helped to resolve the cause of PV reconnection. Some reports demonstrated that the association between reconnection and lower CF value. Linear ablation has more variation to interrupt block and reconnection was more often than PV isolation. The association between CF values and successful linear block has not been revealed yet. In addition, the investigators aim to the effectiveness and safety of linear ablation by using CF sensing catheter.

Interventions

PROCEDUREPulmonary vein isolation

A pulmonary vein isolation procedure will be performed using radiofrequency ablation with contact force monitoring.

PROCEDUREContact force assisted left atrial linear ablation

Left atrial linear ablation (Roof line and Anterior line) after pulmonary vein isolation during catheter ablation for persistent atrial fibrillation monitoring contact force.

PROCEDUREleft atrial linear ablation without contact force monitoring

Left atrial linear ablation (Roof line and Anterior line) after pulmonary vein isolation during catheter ablation for persistent atrial fibrillation without monitoring contact force.

Sponsors

Biosense Webster, Inc.
CollaboratorINDUSTRY
Korea University Anam Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients age is18 years or greater * Patients with persistent AF (AF episode lasting \> 7 days) * Patients with symptomatic AF that is refractory to at least one antiarrhythmic medication * Patients with recurrent or sustained arrhythmia after pulmonary vein isolation * Patients undergoing a first-time ablation procedure for AF * At least one episode of AF must have been documented by ECG, Holter, loop recorder, telemetry, trans telephonic monitoring (TTM), or implantable device within last 2 years of enrollment in this investigation * Patients must be able and willing to provide written informed consent to participate in this investigation

Exclusion criteria

* Patients with long-standing persistent AF; * Long-standing persistent AF will be defined as a sustained episode lasting more than 3 years. * Patients for whom cardioversion or sinus rhythm will never be attempted/pursued; * Patients with AF felt to be secondary to an obvious reversible cause * Patients with contraindications to systemic anticoagulation with heparin or warfarin or a direct thrombin inhibitor; * Patients with left atrial size ≥ 60 mm (2D echocardiography, parasternal long axis view) * Moderate to severe valvular disease * Reduced left ventricular function (ejection fraction \<40%) * Patients who are pregnant. Pregnancy will be assessed by patients informing the physicians.

Design outcomes

Primary

MeasureTime frameDescription
Freedom from atrial fibrillation/atrial tachycardia12 monthsFreedom from any documented episode of atrial fibrillation/atrial tachycardia occurring after a single ablation procedure and lasting longer than 30 seconds with/without antiarrhythmic medication

Secondary

MeasureTime frameDescription
Total radiofrequency energy12 monthsTotal radiofrequency energy to achieve bidirectional block of linear lesion in left atrium
Total force value12 monthsTotal force value for complete block of linear lesion

Countries

South Korea

Contacts

Primary ContactSeung-Young Roh, MD
rsy008@gmail.com+82-10-3612-6876
Backup ContactKwang No Lee, MD
knlee81@naver.com+82-10-9286-1123

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026